Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease

Trial Identifier: D9480C00022
Sponsor: AstraZeneca
NCTID:: NCT04727528
Start Date: March 2021
Primary Completion Date: September 2022
Study Completion Date: September 2022
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish

Trial Locations

Country Location
US, AL Florence, AL, US, 35630
US, CA Downey, CA, US, 90242
US, CA El Centro, CA, US, 92243
US, CA La Mesa, CA, US, 91942
US, CA Sacramento, CA, US, 95817
US, CA San Diego, CA, US, 92161
US, CA South Gate, CA, US, 90280
US, CA Victorville, CA, US, 92395
US, California Chula Vista, California, US, 91910
US, CO Aurora, CO, US, 80045
US, CO Denver, CO, US, 80230
US, CT Middlebury, CT, US, 06762
US, FL Coral Gables, FL, US, 33134
US, GA Columbus, GA, US, 31904
US, IL Hinsdale, IL, US, 60521
US, MD Takoma Park, MD, US, 20912
US, MO Kansas City, MO, US, 64111
US, NC Asheville, NC, US, 28801
US, NC New Bern, NC, US, 28562
US, NC Winston Salem, NC, US, 27103
US, NV Las Vegas, NV, US, 89128
US, NY Bronx, NY, US, 10461
US, NY Fresh Meadows, NY, US, 11365
US, OH Cincinnati, OH, US, 45220
US, OK Lawton, OK, US, 73505
US, PA Danville, PA, US, 17822
US, PA Pittsburgh, PA, US, 15261
US, PR San Juan, PR, US, 00918
US, RI Providence, RI, US, 02903
US, SC Spartanburg, SC, US, 29306
US, TN Chattanooga, TN, US, 37404
US, TN Memphis, TN, US, 38163
US, TX Dallas, TX, US, 75246
US, TX Dallas, TX, US, 75230
US, TX Houston, TX, US, 77004
US, TX San Antonio, TX, US, 78258
US, TX Shenandoah, TX, US, 77384
US, VA Alexandria, VA, US, 22304
US, VA Norfolk, VA, US, 23510
US, WA Bellevue, WA, US, 98004
US, WI Milwaukee, WI, US, 53226